Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus

BACKGROUND/AIMS: Adefovir dipivoxil (ADV) is a nucleotide analogue that is effective against lamivudine-resistant hepatitis B virus (HBV). The aim of this study was to determine the long-term clinical outcomes after ADV rescue therapy in decompensated patients infected with lamivudine-resistant HBV....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Woo, Hyun Young, Choi, Jong Young, Yoon, Seung Kew, Suh, Dong Jin, Paik, Seung Woon, Han, Kwang Hyub, Um, Soon Ho, Kim, Byung Ik, Lee, Heon Ju, Cho, Mong, Lee, Chun Kyon, Kim, Dong Joon, Hwang, Jae Seok
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Korean Association for the Study of the Liver 2014
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4099332/
https://ncbi.nlm.nih.gov/pubmed/25032183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2014.20.2.168
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi